132 related articles for article (PubMed ID: 1390333)
1. Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens.
Brembilla-Perrot B; Aliot E; Clementy J; Cosnay P; Djiane P; Fauchier JP; Kacet S; Lellouche D; Mabo P; Richard M
Cardiovasc Drugs Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1390333
[TBL] [Abstract][Full Text] [Related]
2. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias.
Roy D; Montigny M; Klein GJ; Sharma AD; Cassidy D
Am J Cardiol; 1987 Jan; 59(1):89-92. PubMed ID: 3492906
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects of bepridil in patients with refractory ventricular tachycardia assessed by programmed electrical stimulation.
Schmitt C; Brachmann J; Hölzel C; Waldecker B; Schöls W; Beyer T; Kübler W
Clin Cardiol; 1990 Dec; 13(12):864-8. PubMed ID: 2282730
[TBL] [Abstract][Full Text] [Related]
5. [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study].
Lévy S; Metge M; Cointe R; Labrunie P; Valeix P; Gérard R
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():63-6. PubMed ID: 3938261
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic and antiarrhythmic properties of bepridil.
Prystowsky EN
Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of flecainide in pacing-induced sustained ventricular tachyarrhythmias: correlation to clinical parameters and tachycardia-characteristics.
Podczeck A; Borggrefe M; Bartels K; Breithardt G
Eur Heart J; 1989 Oct; 10(10):928-34. PubMed ID: 2513204
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
Weintraub AR; Manolis AS; Estes NA
Am J Cardiol; 1990 Oct; 66(12):947-53. PubMed ID: 2121017
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia.
Shannon JA; Hammill SC; Gersh BJ
Mayo Clin Proc; 1991 Nov; 66(11):1114-9. PubMed ID: 1943242
[TBL] [Abstract][Full Text] [Related]
12. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
[TBL] [Abstract][Full Text] [Related]
13. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
14. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of therapeutic interventions of sustained monomorphic ventricular tachycardia guided by an electrophysiologic study: a case report].
Niwano S; Aizawa Y; Ebe K; Miyajima S; Funazaki T; Suzuki K; Satoh M; Shibata A
J Cardiol; 1988 Dec; 18(4):1155-62. PubMed ID: 3267724
[TBL] [Abstract][Full Text] [Related]
16. Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. The Encainide-Ventricular Tachycardia Study Group.
Am J Cardiol; 1988 Sep; 62(9):571-5. PubMed ID: 3137797
[TBL] [Abstract][Full Text] [Related]
17. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
18. [Successful hybrid therapy combined with oral bepridil and ICD in a patient with amiodarone refractory life-threatening ventricular tachyarrhythmia associated with ischemic cardiomyopathy].
Oginosawa Y; Abe H; Suzuki Y; Okazaki M; Nakashima Y
J UOEH; 2002 Sep; 24(3):337-43. PubMed ID: 12235963
[TBL] [Abstract][Full Text] [Related]
19. Sustained ventricular tachycardia responsive to verapamil in patients with hypertrophic cardiomyopathy. Clinical and electrophysiological assessment of drug efficacy.
Miyajima S; Aizawa Y; Suzuki K; Satoh M; Niwano S; Ebe K; Fujita T; Ishiguro J; Hirokawa Y; Shibata A
Jpn Heart J; 1989 Mar; 30(2):241-9. PubMed ID: 2724542
[TBL] [Abstract][Full Text] [Related]
20. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias.
Budde T; Borggrefe M; Podczeck A; Martinez-Rubio A; Breithardt G
J Cardiovasc Pharmacol; 1991 Aug; 18(2):254-60. PubMed ID: 1717787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
